IRIDEX Corporation (IRIX)

Market Cap	34.42M
Revenue (ttm)	57.29M
Net Income (ttm)	-7.25M
Shares Out	16.01M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,297
Open	2.16
Previous Close	2.16
Day's Range	2.12 - 2.24
52-Week Range	1.96 - 3.49
Beta	1.26
Analysts	Hold
Price Target	3.00 (+37.87%)
Earnings Date	May 11, 2023

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems tha...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 130
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX

Financial Performance

In 2022, IRIDEX's revenue was $56.97 million, an increase of 5.69% compared to the previous year's $53.90 million. Losses were -$7.55 million, 44.4% more than in 2022.

Analyst Forecast

According to one analyst, the rating for IRIX stock is "Hold" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(37.87% upside)

Analyst Consensus: Hold